AEGiS-UPI: Possible HIV epidemic in Afghanistan United Press InternationalImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Possible HIV epidemic in Afghanistan

United Press International - August 29, 2007


KABUL, Afghanistan, Aug. 29 (UPI) -- A U.S. researcher working in Kabul, Afghanistan, warns increasing injection drug use and accompanying high-risk behaviors could lead to an HIV epidemic.

"Our findings suggest that interventions to reduce high-risk behaviors among injection drug users are urgently needed in Afghanistan," says Dr. Catherine S. Todd, of the University of California, San Diego. "The window of opportunity is rapidly closing to avert an HIV epidemic among Afghan injection drug users."

The researcher team surveyed 464 injection drug users in Kabul age 18 and older between June 2005 and June 2006. In this group of Afghan males, high-risk behaviors were common. For instance, 50 percent were sharing syringes and 76 percent had paid for sex with a woman. More than half had been incarcerated in prison, 21 percent of them, more than once.

The prevalence of infection with HIV was calculated at about 3 percent, while 38 percent of the respondents tested positive for Hepatitis C infection. The high prevalence of hepatitis C may potentially foreshadow an HIV epidemic because the infections share common risk factors.

The study, published in the journal Emerging Infectious Diseases, concludes an increase of needle exchange and other harm-reduction programs, particularly in prisons, is necessary.


070829
UPI070824


Copyright © 2007 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .